Faeth Therapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Faeth Therapeutics Inc
CIK #0001829802, 0002100543
EDGAR Form CIK 2011 - 2026
10-K [0001829802]
10-Q [0001829802]
3 [0001829802]
4 [0001829802]
8-K [0001829802]
D [0001829802]
SC 13D [0001829802]
SC 13G [0001829802]
D [0002100543]
Form 13D/13G Filer Form 13D/13G Subject Filed
Suvretta Capital Management LLC Faeth Therapeutics Inc [2026-06-23]
S2G Investments LLC Faeth Therapeutics Inc [2026-06-23]
Millennium Management LLC Sensei Biotherapeutics Inc [2026-05-15]
Caligan Partners LP Sensei Biotherapeutics Inc [2026-05-15]
Stempoint Capital LP Sensei Biotherapeutics Inc [2026-05-15]
Trails Edge Capital Partners LP Sensei Biotherapeutics Inc [2026-02-25]
Newtyn Management LLC Sensei Biotherapeutics Inc [2023-11-03]
Apeiron Investment Group Ltd Sensei Biotherapeutics Inc [2022-07-19]
H&S Investments I LP Sensei Biotherapeutics Inc [2022-02-14]
Apeiron Investment Group Ltd Sensei Biotherapeutics Inc [2021-02-18]
View All
Form 3/4/5 Subject 2011 - 2026
Faeth Therapeutics Inc
Stephenson Brian C
Parikh Anand Kiran
Ramasastry Saira
Hahn Stephen M
Holmen Bob
Donenberg Philip B
Gerry Christopher
Cambrian BioPharma Inc
Peyer James
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Faeth Therapeutics Inc SNSE
Employee Stock Option (right to buy) · derivative
2026-02-19 Grant 1,239,305 $0.00
Faeth Therapeutics Inc SNSE
Employee Stock Option (right to buy) · derivative
2026-02-17 Grant 92,533
Faeth Therapeutics Inc SNSE
Employee Stock Option (right to buy) · derivative
2026-02-17 Grant 56,673
Faeth Therapeutics Inc SNSE
Series B Preferred Stock · derivative
2026-02-17 Grant 809,822
Faeth Therapeutics Inc SNSE
Stock Option (right to buy) · derivative
2026-02-13 Grant 1,900 $0.00
Faeth Therapeutics Inc SNSE
Common Stock
2025-12-09 Sell 2,666 $7.95 21,195
Faeth Therapeutics Inc SNSE
Common Stock
2025-12-09 Option exercise 395 $6.40 2,528
Faeth Therapeutics Inc SNSE
Common Stock
2025-12-09 Sell 395 $8.04 3,176
Faeth Therapeutics Inc SNSE
Common Stock
2025-12-09 Sell 2,666 $7.95 21,195
Faeth Therapeutics Inc SNSE
Common Stock
2025-12-09 Sell 446 $7.92 3,532
Faeth Therapeutics Inc SNSE
Common Stock
2025-12-09 Option exercise 395 $6.40 2,528
Faeth Therapeutics Inc SNSE
Stock Option (Right to Buy) · derivative
2025-12-09 Option exercise 395 $0.00
Faeth Therapeutics Inc SNSE
Common Stock
2025-12-09 Sell 3,105 $8.59 26,672
Faeth Therapeutics Inc SNSE
Stock Option (Right to Buy) · derivative
2025-12-09 Option exercise 395 $0.00
Faeth Therapeutics Inc SNSE
Common Stock
2025-12-09 Sell 446 $7.92 3,532
Faeth Therapeutics Inc SNSE
Common Stock
2025-12-09 Sell 395 $8.04 3,176
Faeth Therapeutics Inc SNSE
Common Stock
2025-12-08 Sell 3,105 $8.59 26,672
Faeth Therapeutics Inc SNSE
Common Stock
2025-12-05 Sell 14,508 $11.40 165,391
Faeth Therapeutics Inc SNSE
Common Stock
2025-12-05 Sell 42 $13.16 553
Faeth Therapeutics Inc SNSE
Common Stock
2025-12-05 Sell 1,745 $12.29 21,446
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com